基于外显子跳跃的结直肠癌亚型分类
研究利用无监督聚类分析可变剪接与共识分子亚型(CMS)的关联,构建基于29个外显子跳跃事件的分类器,并在两个独立来源的未见结直肠癌样本(Indivumed n=129;癌症基因组图谱 n=99)中验证,该分类器能准确分类肿瘤并较基因表达分类器更精确区分具有不同生物学和预后特征的亚型。
要点
- 基于29个外显子跳跃事件构建的结直肠癌亚型分类器可准确分类单个患者标本。
- 该分类器在Indivumed(n=129)和癌症基因组图谱(n=99)的未见肿瘤中验证了性能。
- 与基于基因表达的分类器相比,该分类器能更精确区分具有不同生物学和预后特征的亚型。
核心结论
- 少量外显子跳跃事件即可利用单个患者标本可靠地对结直肠癌进行亚型分类,方式适合临床应用。
研究设计与样本
- 研究采用无监督聚类衡量不同类别可变剪接与共识分子亚型(CMS)的关联强度。
- 以基因水平量化的表达数据作为CMS标签的金标准,通过自助法和L1惩罚估计进行特征选择。
- 利用所得特征空间构建适用于单样本和多样本的亚型预测框架。
- 在来自2个独立来源的未见结直肠癌标本(Indivumed,n=129;癌症基因组图谱,n=99)上评估模型性能。
主要发现
- 研究开发了基于29个外显子跳跃事件的结直肠癌亚型识别器,能准确分类未见肿瘤。
- 与基于基因表达的分类器相比,该识别器能更精确区分具有不同生物学和预后特征的亚型。
关键数值与推荐
- 基于29个外显子跳跃事件的分类器在Indivumed(n=129)和癌症基因组图谱(n=99)的未见结直肠癌中验证。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The identification of colorectal cancer (CRC) molecular subtypes has prognostic and potentially diagnostic value for patients, yet reliable subtyping remains unavailable in the clinic. The current consensus molecular subtype (CMS) classification in CRCs is based on complex RNA expression patterns quantified at the gene level. The clinical application of these methods, however, is challenging due to high uncertainty of single-sample classification and associated costs. Alternative splicing, which strongly contributes to transcriptome diversity, has rarely been used for tissue type classification. Here, we present an AS-based CRC subtyping framework sensitive to differential exon use that can be adapted for clinical application. METHODS: Unsupervised clustering was used to measure the strength of association between different categories of alternative splicing and CMSs. To build a classifier, the ground truth for CMS labels was derived from expression data quantified at the gene level. Feature selection was achieved through bootstrapping and L1-penalized estimation. The resulting feature space was used to construct a subtype prediction framework applicable to single and multiple samples. The performance of the models was evaluated on unseen CRCs from 2 independent sources (Indivumed, n = 129; The Cancer Genome Atlas, n = 99). RESULTS: We developed a CRC subtype identifier based on 29 exon-skipping events that accurately classifies unseen tumors and enables more precise differentiation of subtypes characterized by distinct biological and prognostic features as compared to classifiers based on gene expression. CONCLUSIONS: Here, we demonstrate that a small number of exon-skipping events can reliably classify CRC subtypes using individual patient specimens in a manner suitable to clinical application.
引用
- Ambeskovic A, McCall MN, Woodsmith J, et al. Exon-Skipping-Based Subtyping of Colorectal Cancers. Gastroenterology. 2024. PMID: 39181169. doi:10.1053/j.gastro.2024.08.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。